0
Tobacco Cessation |

Cross Sectional Survey of Electronic Cigarettes Use Among Ambulatory COPD Patients

Laith Ghazala, MD; Judith Gordon, PhD; Cristine Berry, MD; Christian Bime, MD; Lynn Gerald, PhD; Todd Golden; Kawanjit Sekhon, MD
Author and Funding Information

Department of Medicine, University of Arizona, Tucson, AZ


Chest. 2015;148(4_MeetingAbstracts):1076A. doi:10.1378/chest.2256166
Text Size: A A A
Published online

Abstract

SESSION TITLE: Tobacco Cessation and Prevention Posters

SESSION TYPE: Original Investigation Poster

PRESENTED ON: Wednesday, October 28, 2015 at 01:30 PM - 02:30 PM

PURPOSE: Electronic cigarette (EC) use has grown increasingly popular in spite of substantial debate regarding their safety and efficacy with respect to increasing cessation of conventional cigarettes. In this study, we are assessing experience and beliefs about EC among adults with chronic obstructive pulmonary disease (COPD)

METHODS: We developed a 15-item written self-administered questionnaire (COPD-Electronic Nicotine Devices survey) to query COPD patients regarding their EC use, and beliefs about EC risks and benefits. We plan to administer this survey to 100 COPD patients attending ambulatory clinics at Banner University Medical Center in Tucson. Our cross-sectional study was approved by the local IRB and is ongoing

RESULTS: To date, 32 COPD patients have completed the survey, including 22 males and 10 females with mean age of 68 (SD 8.65) years. Among these participants, 11 individuals (34.3%) reported ever using EC. Among EC users, 8 (72.7%) reported using EC on a daily basis, the majority of whom “vaped” as an alternative to smoking conventional cigarettes (n=10, 91%). Nine EC users (81.8%) believed that EC use reduced the number of conventional cigarettes they smoked. The majority (n=8, 72.7%) believed EC are not bad for their health. Four participants (36.4%) reported using EC because they taste better than conventional cigarettes, and six (54.5%) individuals described using EC because they can “vape” in places where conventional cigarettes are prohibited. Fifteen participants (46.9%) indicated that they do not know the effects of EC on health, whereas 9 subjects (28.1%) believed EC are less harmful, and 6 subjects (18.8%) believed EC are equally harmful to conventional cigarettes and only 2 subjects (6.3%) believed EC are more harmful than conventional cigarettes

CONCLUSIONS: EC use is relatively common among ambulatory COPD patients, and some users report reduction in conventional cigarette consumption, however debate among COPD patients regarding the effects of EC on health is continuing

CLINICAL IMPLICATIONS: EC could be a useful tool for smoking cessation among COPD patients, but the long-term effect of EC needs to be studied and compared to other methods of smoking cessation

DISCLOSURE: The following authors have nothing to disclose: Laith Ghazala, Judith Gordon, Cristine Berry, Christian Bime, Lynn Gerald, Todd Golden, Kawanjit Sekhon

No Product/Research Disclosure Information


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543